Rilpivirine an option in some HIV patients

NEW YORK (Reuters Health) - Rilpivirine (RPV, Edurant) plus two nucleoside/tide reverse transcriptase inhibitors is a "valuable" option for treatment-naive HIV-1-infected adults with baseline viral load no higher than 100,000 copies/ml, AIDS researchers from France and Belgium say.
Source: Modern Medicine - Category: Journals (General) Source Type: news